A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Ferrous and Polysacchride Iron Vitamin Mineral Complex Supplement (Integra Plus)

Ferrous and Polysacchride Iron Vitamin Mineral Complex Supplement supplements vitamin C (ascorbic acid).

First FDA approval2009-04-27
Generic availableNo (brand-only)
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one
Lowest NADAC
$0.654/unit
2 NDCs benchmarked, lowest of all strengths.
Average NADAC
$0.675
Across all dosage forms in distribution.
Highest NADAC
$0.695
Range is tight.
Plans with PA
0 / 329
Zero PA friction — switching is purely formulary.

Questions a plan sponsor actually asks.

FAQPage schema8 entries indexed · 4 visible
What is Ferrous and Polysacchride Iron Vitamin Mineral Complex Supplement used for?

Ferrous and Polysacchride Iron Vitamin Mineral Complex Supplement supplements vitamin C (ascorbic acid).

Is there a generic for Ferrous and Polysacchride Iron Vitamin Mineral Complex Supplement?

No. Ferrous and Polysacchride Iron Vitamin Mineral Complex Supplement is brand-only with no generic equivalents currently in market.

How much does my plan pay for Ferrous and Polysacchride Iron Vitamin Mineral Complex Supplement?

Across 329 Part D plans, Ferrous and Polysacchride Iron Vitamin Mineral Complex Supplement averages $0.675/unit (NADAC). Lowest available: $0.654/unit. Highest in distribution: $0.695/unit.

Is Ferrous and Polysacchride Iron Vitamin Mineral Complex Supplement on the FDA shortage list?

No. Ferrous and Polysacchride Iron Vitamin Mineral Complex Supplement is not currently on the FDA Drug Shortage Database.

4 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file (2 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.